Wells Fargo Maintains Equal-Weight on NeuroPace, Raises Price Target to $9
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Lawrence Biegelsen has maintained an Equal-Weight rating on NeuroPace (NASDAQ:NPCE) and raised the price target from $6 to $9.
October 04, 2023 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Equal-Weight rating on NeuroPace and raised the price target from $6 to $9.
The raised price target by Wells Fargo indicates a positive outlook for NeuroPace. This could potentially lead to an increase in the stock price in the short term as it signals the analyst's increased confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100